Sponsors (25)
Official title: To address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes.
Introduced May 14, 2026 by Debbie Wasserman Schultz · Last progress May 14, 2026
The bill substantially expands survivorship care, supports, research, and standardized care planning for cancer survivors — improving long‑term outcomes and equity — but does so at significant fiscal and administrative cost and with risks of uneven access, privacy challenges, and implementation burdens.
Millions of cancer survivors (Medicare and Medicaid enrollees, and survivors across ages) gain guaranteed survivorship services — written/electronic care plans, regular transition visits, navigation, mental‑health and genetic counseling — improving continuity of care and long‑term outcomes.
Medicaid and CHIP enrollees (especially children, adolescents, and low‑income patients) get guaranteed coverage for fertility preservation and related services without cost‑sharing, improving reproductive options after cancer.
Federal research, a coordinating office and GAO/stakeholder reviews focus more funding and attention on late and long‑term effects of cancer, professional education, and patient experience data — likely improving evidence, clinical guidance, and survivor outcomes over time.
Expanding Medicare, Medicaid, CHIP benefits, fertility preservation mandates, research programs, and grant funding will increase federal and state spending and could require higher taxes, deficits, or tradeoffs with other programs.
Providers, state agencies, and health systems face substantial administrative and operational burdens — new benefit designs, documentation, care plans, reporting, EHR changes, training and coordination — which could strain capacity and slow implementation.
The law could produce uneven access across states and territories (optional territory mandates, state variation allowed by comparability bypass), leaving some survivors with weaker benefits depending on where they live.
Based on analysis of 11 sections of legislative text.
Expands survivorship care by mandating Medicaid/CHIP fertility coverage, authorizing survivorship transition services, creating NCI Office of Cancer Survivorship, Medicare planning-payment, grants, APMs, and GAO study.
Creates a federal framework to expand and coordinate cancer survivorship care across Medicaid, CHIP, Medicare, and federal programs. It requires Medicaid and CHIP coverage of fertility services for people diagnosed with cancer, allows States to offer defined survivorship transition services outside normal Medicaid comparability rules, establishes a new Office of Cancer Survivorship at NCI, creates Medicare-covered cancer care planning and coordination services with a payment mechanism, and funds grants, workforce supports, and demonstration models to improve long‑term survivorship care and transitions. Also directs HHS to develop alternative payment models for survivorship care, requires a stakeholder process and IT/privacy evaluation for consolidating survivorship treatment histories, funds workforce and supportive services grants via Labor, launches a survivorship supportive‑care grant program at HHS, and commissions a GAO study of survivorship progress and gaps. Effective dates vary by provision (some ~12–18 months; Medicare payment rules start the first calendar year after enactment; CHIP amendment effective Oct 1, 2026).